These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 17611753)

  • 1. Characterization of Fusarium graminearum inhibitory lipopeptide from Bacillus subtilis IB.
    Wang J; Liu J; Chen H; Yao J
    Appl Microbiol Biotechnol; 2007 Sep; 76(4):889-94. PubMed ID: 17611753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of biosurfactant lipopeptides Iturin A, fengycin and surfactin A from Bacillus subtilis CMB32 for control of Colletotrichum gloeosporioides.
    Kim PI; Ryu J; Kim YH; Chi YT
    J Microbiol Biotechnol; 2010 Jan; 20(1):138-45. PubMed ID: 20134245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Purification and identification of iturin A from Bacillus subtilis JA by electrospray ionization mass spectrometry].
    Chen H; Yuan C; Cai K; Zheng Z; Yu Z
    Wei Sheng Wu Xue Bao; 2008 Jan; 48(1):116-20. PubMed ID: 18338587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fengycin antibiotics isolated from B-FS01 culture inhibit the growth of Fusarium moniliforme Sheldon ATCC 38932.
    Hu LB; Shi ZQ; Zhang T; Yang ZM
    FEMS Microbiol Lett; 2007 Jul; 272(1):91-8. PubMed ID: 17490402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and structural analysis of bamylocin A, novel lipopeptide from Bacillus amyloliquefaciens LP03 having antagonistic and crude oil-emulsifying activity.
    Lee SC; Kim SH; Park IH; Chung SY; Choi YL
    Arch Microbiol; 2007 Oct; 188(4):307-12. PubMed ID: 17530228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESI LC-MS and MS/MS characterization of antifungal cyclic lipopeptides produced by Bacillus subtilis XF-1.
    Li XY; Mao ZC; Wang YH; Wu YX; He YQ; Long CL
    J Mol Microbiol Biotechnol; 2012; 22(2):83-93. PubMed ID: 22614917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of the Gibberella zeae growth inhibitory lipopeptides from a Bacillus subtilis mutant by ion beam implantation.
    Liu J; Liu M; Wang J; Yao JM; Pan RR; Yu ZL
    Appl Microbiol Biotechnol; 2005 Nov; 69(2):223-8. PubMed ID: 15838674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fengycin--a novel antifungal lipopeptide antibiotic produced by Bacillus subtilis F-29-3.
    Vanittanakom N; Loeffler W; Koch U; Jung G
    J Antibiot (Tokyo); 1986 Jul; 39(7):888-901. PubMed ID: 3093430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and structural characterization of bacillomycin F produced by a bacterial honey isolate active against Byssochlamys fulva H25.
    Lee H; Churey JJ; Worobo RW
    J Appl Microbiol; 2008 Sep; 105(3):663-73. PubMed ID: 18397260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of a C12-lipopeptide produced by Bacillus subtilis HSO 121.
    Liu XY; Yang SZ; Mu BZ
    J Pept Sci; 2008 Jul; 14(7):864-75. PubMed ID: 18265435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and characterization of Iturinic lipopeptides as antifungal agents and biosurfactants produced by a marine pinctada martensii-derived Bacillus mojavensis B0621A.
    Ma Z; Hu J
    Appl Biochem Biotechnol; 2014 Jun; 173(3):705-15. PubMed ID: 24699814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coproduction of surfactin and iturin A, lipopeptides with surfactant and antifungal properties, by Bacillus subtilis.
    Sandrin C; Peypoux F; Michel G
    Biotechnol Appl Biochem; 1990 Aug; 12(4):370-5. PubMed ID: 2119191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of lipopeptide isoforms by MALDI-TOF-MS/MS based on the simultaneous purification of iturin, fengycin, and surfactin by RP-HPLC.
    Yang H; Li X; Li X; Yu H; Shen Z
    Anal Bioanal Chem; 2015 Mar; 407(9):2529-42. PubMed ID: 25662934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of lipopeptide antibiotics produced by Bacillus subtilis.
    Chen H; Wang L; Su CX; Gong GH; Wang P; Yu ZL
    Lett Appl Microbiol; 2008 Sep; 47(3):180-6. PubMed ID: 19552782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fengycin C produced by Bacillus subtilis EA-CB0015.
    Villegas-Escobar V; Ceballos I; Mira JJ; Argel LE; Orduz Peralta S; Romero-Tabarez M
    J Nat Prod; 2013 Apr; 76(4):503-9. PubMed ID: 23461648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal lipopeptides from Bacillus amyloliquefaciens strain BO7.
    Romano A; Vitullo D; Di Pietro A; Lima G; Lanzotti V
    J Nat Prod; 2011 Feb; 74(2):145-51. PubMed ID: 21235220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Purification and characterization of antifungal peptide LP-1].
    Liu Y; Xu Q; Chen Z
    Wei Sheng Wu Xue Bao; 1999 Oct; 39(5):441-7. PubMed ID: 12555526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LC/ESI-MS/MS characterisation of lipopeptide biosurfactants produced by the Bacillus licheniformis V9T14 strain.
    Pecci Y; Rivardo F; Martinotti MG; Allegrone G
    J Mass Spectrom; 2010 Jul; 45(7):772-8. PubMed ID: 20623484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of fengycin homologues from Bacillus subtilis with ESI-MS/CID.
    Bie X; Lu Z; Lu F
    J Microbiol Methods; 2009 Dec; 79(3):272-8. PubMed ID: 19781583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacillus subtilis SSE4 produces subtulene A, a new lipopeptide antibiotic possessing an unusual C15 unsaturated beta-amino acid.
    Thasana N; Prapagdee B; Rangkadilok N; Sallabhan R; Aye SL; Ruchirawat S; Loprasert S
    FEBS Lett; 2010 Jul; 584(14):3209-14. PubMed ID: 20541548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.